Semaglutide improves heart health and reduces weight in obese patients, but with side effects
Can't see this email? View it online
   
  Gastroenterology Gastroenterology logo  
  The latest gastroenterology‎ news from News Medical  
 Can magnesium supplements help you sleep better?Can magnesium supplements help you sleep better?
 
Magnesium plays a crucial role in sleep quality, with dietary intake and supplements influencing sleep duration and reducing insomnia in various populations.
 
 
 Semaglutide improves heart health and reduces weight in obese patients, but with side effectsSemaglutide improves heart health and reduces weight in obese patients, but with side effects
 
Semaglutide significantly reduces cardiovascular events and adverse effects in overweight and obese patients. The study highlights semaglutide's superiority over other GLP-1 agonists for cardiovascular health.
 
   Baylor scientist earns NIH grant for personalized microbiome treatmentsBaylor scientist earns NIH grant for personalized microbiome treatments
 
Baylor University researcher Aaron Wright, Ph.D., has earned a $5.6 million National Institutes of Health (NIH) Director's Transformative Research Award for a project that he and collaborators hope could lead to personalized – and revolutionary – treatments for gut microbiome diseases like Irritable Bowel Syndrome (IBS), Crohn's, Ulcerative Colitis and more.
 
   Scientists discover gut microbiome differences in children with autismScientists discover gut microbiome differences in children with autism
 
Researchers found differences in gut bacteria between children with autism and typically developing children but caution that more research is needed to clarify these associations and their therapeutic potential.
 
   Early signs of inflammatory bowel disease detected in newbornsEarly signs of inflammatory bowel disease detected in newborns
 
Across the Western world, the prevalence of these chronic and serious conditions, which have no cure, is rising. In Denmark alone, 50,000 people suffer from either Crohn's disease or ulcerative colitis, which represents a doubling in cases over the past 20 years.
 
 FDA-approved breast cancer drug shows promise for appendix cancer
 
FDA-approved breast cancer drug shows promise for appendix cancerResearchers at University of California San Diego School of Medicine found an FDA-approved drug used to treat breast cancer has the potential to be an effective therapeutic for a specific type of appendix cancer.
 
 
 Cleveland Clinic integrates AI-powered platform to enhance digestive disease care
 
Cleveland Clinic integrates AI-powered platform to enhance digestive disease careTo expand access to care for patients, Cleveland Clinic has added Ayble Health, an AI-enabled digital care platform, to its multidisciplinary care model for the treatment of chronic digestive diseases.
 
 
 New genetic variant may predict severe ulcerative colitis in patients
 
New genetic variant may predict severe ulcerative colitis in patientsAbdominal pain, diarrhea, and debilitating fatigue define the daily lives of millions of people worldwide who suffer from chronic bowel disease.
 
 
 Candida overgrowth in the gut
 
Candida overgrowth in the gutCandida overgrowth can disrupt gut health, leading to serious conditions. Explore the factors contributing to this issue and potential treatment approaches.
 
 
 Novel app enables surveillance of global travel-related illness
 
Novel app enables surveillance of global travel-related illnessOn around one in three trips someone falls ill, with gastrointestinal and respiratory complaints among the most common symptoms.
 
 
 $1.9 million grant aims to improve infant safety against necrotizing enterocolitis
 
$1.9 million grant aims to improve infant safety against necrotizing enterocolitisA University of Arizona College of Nursing-led research team will use a $1.9 million Department of Health and Human Services grant to lead a nationwide effort to keep babies safe from the deadly threat of necrotizing enterocolitis, known as NEC.